MARKET

DNA

DNA

Ginkgo Bioworks Holdings Inc
NYSE
5.93
-0.48
-7.49%
After Hours: 5.93 0 0.00% 19:49 03/27 EDT
OPEN
6.42
PREV CLOSE
6.41
HIGH
6.43
LOW
5.88
VOLUME
1.63M
TURNOVER
--
52 WEEK HIGH
17.58
52 WEEK LOW
5.00
MARKET CAP
367.21M
P/E (TTM)
-1.0515
1D
5D
1M
3M
1Y
5Y
1D
Ginkgo Bioworks: Shedding Biosecurity And Doubling Down On Autonomy
Seeking Alpha · 2d ago
Weekly Report: what happened at DNA last week (0316-0320)?
Weekly Report · 5d ago
Weekly Report: what happened at DNA last week (0309-0313)?
Weekly Report · 03/16 09:32
Ginkgo Bioworks Posts On X "New in @sciam today: Researchers at Ginkgo and @OpenAI showed that an AI model working with an autonomous lab can design and iterate real biology experiments at unprecedented speed. From San Francisco, where GPT-5 designed the experiments to our autonomous lab in Boston that ran 36,000 #CFPS tests over 6 months. ..."
Benzinga · 03/13 16:30
Ginkgo Bioworks price target lowered to $5 from $9 at BTIG
TipRanks · 03/12 11:31
Ginkgo Bioworks Holdings Is Maintained at Sell by BTIG
Dow Jones · 03/12 11:21
Ginkgo Bioworks Holdings Price Target Cut to $5.00/Share From $9.00 by BTIG
Dow Jones · 03/12 11:21
BTIG Maintains Sell on Ginkgo Bioworks Holdings, Lowers Price Target to $5
Benzinga · 03/12 11:12
More
About DNA
Ginkgo Bioworks Holdings, Inc. operates as a horizontal platform for cell programming, providing end-to-end services for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. Its segments include Cell Engineering and Biosecurity. The Cell Engineering consists of research and development services performed under collaboration and license agreements relating to its cell programming platform. Its cell programming platform includes two core assets: the Foundry, and Codebase. The Biosecurity segment consists of biomonitoring and bioinformatics support services, offered to both government and non-government customers through its two core offerings: Canopy and Horizon. The Company provides comprehensive research and development services spanning the genetic medicine modalities: gene therapy, cell therapy and gene editing, and RNA therapeutics.

Webull offers Ginkgo Bioworks Holdings Inc stock information, including NYSE: DNA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, DNA stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading DNA stock methods without spending real money on the virtual paper trading platform.